The effect of heparin on the gellation of Pluronic F-127 hydrogel

被引:37
作者
Chung, Yong-Il [1 ]
Lee, Seung-Young [1 ]
Tae, Giyoong [1 ]
机构
[1] Gwangju Inst Sci & Technol, Dept Mat Sci & Engn, Kwangju 500712, South Korea
关键词
sol-gel transition; Pluronic F-127; heparin; PEG; hydrogel;
D O I
10.1016/j.colsurfa.2005.10.060
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
The interaction between heparin and Pluronic polymer was characterized by the sol-gel transition temperature and the theological properties of the heparin-Pluronic hydrogels. The decrease of the transition temperature was consistently shown in all media (distilled water, phosphate buffer, and PBS) as the added amount of heparin increased. In contrast, the addition of PEG produced the increase of the transition temperature. The order of phase transition with increasing temperature (heparin-Pluronic > Pluronic > PEG-Pluronic) obtained from the change in the storage modulus of the Pluronic solutions well coincided with the results obtained from the inverting vial method; a plateau of storage modulus in frequency sweep was developed at the lowest temperature for the heparin-Pluronic hydrogel, and the plateau modulus of the heparin-Pluronic hydrogel was higher than that of the pure Pluronic hydrogel near the sol-gel transition boundary. These results demonstrate that the interaction between heparin and Pluronic polymer exists, which promotes the Pluronic micelle-micelle association. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:480 / 484
页数:5
相关论文
共 30 条
[1]   POLY(ETHYLENE OXIDE)-POLY(PROPYLENE OXIDE)-POLY(ETHYLENE OXIDE) BLOCK-COPOLYMER SURFACTANTS IN AQUEOUS-SOLUTIONS AND AT INTERFACES - THERMODYNAMICS, STRUCTURE, DYNAMICS, AND MODELING [J].
ALEXANDRIDIS, P ;
HATTON, TA .
COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS, 1995, 96 (1-2) :1-46
[2]   Absorption of insulin from Pluronic F-127 gels following subcutaneous administration in rats [J].
Barichello, JM ;
Morishita, M ;
Takayama, K ;
Nagai, T .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1999, 184 (02) :189-198
[3]   Controlled-release delivery system for the alpha-MSH analog melanotan-I using poloxamer 407 [J].
Bhardwaj, R ;
Blanchard, J .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1996, 85 (09) :915-919
[4]   LINEAR VISCOELASTICITY AT THE GEL POINT OF A CROSS-LINKING PDMS WITH IMBALANCED STOICHIOMETRY [J].
CHAMBON, F ;
WINTER, HH .
JOURNAL OF RHEOLOGY, 1987, 31 (08) :683-697
[5]  
CHAMBON F, 1985, POLYM BULL, V13, P499
[6]   Bone morphogenetic protein excipients: Comparative observations on poloxamer [J].
Clokie, CML ;
Urist, MR .
PLASTIC AND RECONSTRUCTIVE SURGERY, 2000, 105 (02) :628-637
[7]  
DIBIASE MD, 1991, PHARM ACTA HELV, V66, P165
[8]   CONTROLLED AND MODULATED RELEASE OF BASIC FIBROBLAST GROWTH-FACTOR [J].
EDELMAN, ER ;
MATHIOWITZ, E ;
LANGER, R ;
KLAGSBRUN, M .
BIOMATERIALS, 1991, 12 (07) :619-626
[9]  
GILBERT J C, 1987, Journal of Controlled Release, V5, P113, DOI 10.1016/0168-3659(87)90002-2
[10]   Vascular effects of sustained-release fibroblast growth factors [J].
Hom, DB ;
Medhi, K ;
Assefa, G ;
Juhn, SK ;
Johnston, TP .
ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 1996, 105 (02) :109-116